Align Technology Inc (ALGN) Financial Statements
Historical financial data — 41 statements covering FY2016–FY2025
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90%...
Align Technology Inc's revenue increased 0.9% year over year, from $4.00B to $4.03B.
Net income decreased 2.6% over the same period, from $421.4M to $410.4M.
Over the 9-year period from FY2016 to FY2025, revenue grew by 274% in total.
Operating cash flow declined 19.6% to $593.2M.
Align Technology Inc maintains a healthy net profit margin of 10.2%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2023 | $2.91B+49.4% | $321.0M | $2.04B | $471.8M | $738.9M | $6.32B | N/A | $3.80B |
| Q1 FY2024 | $997.4M-65.7% | $105.0M | $697.8M | $154.1M | $28.7M | $6.16B | N/A | $3.76B |
| Q2 FY2024 | $2.03B+103.1% | $201.6M | $1.42B | $301.2M | $188.5M | $6.16B | N/A | $3.76B |
| Q3 FY2024 | $3.00B+48.3% | $317.6M | $2.10B | $463.5M | $452.2M | $6.37B | N/A | $3.94B |
| Q1 FY2025 | $979.3M-67.4% | $93.2M | $680.1M | $131.1M | $52.7M | $6.10B | N/A | $3.79B |
| Q2 FY2025 | $1.99B+103.4% | $217.8M | $1.39B | $294.1M | $181.3M | $6.22B | N/A | $3.91B |
| Q3 FY2025 | $2.99B+50.0% | $274.6M | $2.03B | $390.4M | $370.0M | $6.23B | N/A | $3.96B |
| Q1 FY2026 | $1.04B-65.2% | $112.8M | $736.6M | $142.0M | $151.0M | $6.31B | N/A | $4.15B |
Balance Sheet Summary (Latest Period)
Total Assets
$6.23B
Total Liabilities
$2.18B
Total Equity
$4.05B
Cash & Equivalents
$1.09B
Total Debt
N/A
Current Assets
$2.62B
Current Liabilities
$1.92B
Retained Earnings
$2.46B